4 Pharma & Biotech Stocks on the Move in April

May 9, 2024

Markets were more subdued in April after the strong start to the year. The S&P/ASX 200 Accumulation Index was down 2.9% and the S&P/ASX Small Ordinaries Accumulation Index was down 3.1%. The Healthcare sector was not immune with the S&P/ASX 300 Healthcare Accumulation Index down 2.3% in April. Despite the subdued markets there was a few companies in the Pharma & Biotech sector that experienced strong share price moves. In this edition of the Movers & Shakers for Pharma & Biotech we take a look at four companies whose share prices rallied during the month.